- Lobbying
- Lobbying by Zydus Pharmaceuticals USA Inc.
Lobbying Relationship
Bills mentioned
H.R.5748: Medicaid Generic Drug Price Fairness Act of 2014
Sponsor: Elijah E. Cummings (D-Md.)
S.2948: Medicaid Generic Drug Price Fairness Act
Sponsor: Bernard Sanders (ID-Vt.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Henry Menn III | CoS, Sen. Bob Graham (01-04) Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commiss (93-95) CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) CoS, Sen. Bob Graham (01 - 04) |
Lisa Layman | SPA, Sen Stabenow (05-07) SPA, Sen. Graham (01-04); LA, Sen Bryan (00) LA, Sen. Chafee (97-99); CBO, PA (92-96) SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) SPA, Sen. Stabenow (05-07) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate